Fundraising Fox

Bain Capital Life Sciences2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

Arcutis BiotherapeuticsNASDAQ: ARQTOct 2019

BiotechWestlake Village, US

Alexander Asam(Director)Ricky Sun(Director)Todd Franklin Watanabe(Executive Officer, Director)

BoardPatrick Heron(Director)inDaniel Estes(Director)inJonathan Silverstein(Director)

Co-investorsRA CapitalFrazier Life Sciences

Savarasavarapharma.cominNASDAQ: SVRADec 2019

Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.

BiotechHealthtechMedical DevicesAustin, US

Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)Mike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)Richard J. Hawkins(Director)An van Es-Johansson(Director)Ricky Sun(Director)

Co-investorsCentral Texas Angel NetworkGreen Park & Golf VenturesKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)

SpringWorks TherapeuticsMar 2019

HealthtechStamford, US

Daniel S. Lynch(Executive Officer, Director)Saqib Islam(Executive Officer, Director)Michael Greco(Executive Officer)

BoardStephen Squinto(Director)inDeval Patrick(Director)Carl L Gordon(Director)in

Co-investorsPfizer Venture InvestmentsOrbiMed

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.